Tech Company Financing Transactions
Solarea Bio Funding Round
On 5/9/2023, Solarea Bio landed $15 million in Series B funding from S2G Ventures, Bold Capital Partners and GG 1978.
Transaction Overview
Company Name
Announced On
5/9/2023
Transaction Type
Venture Equity
Amount
$15,000,000
Round
Series B
Investors
Proceeds Purpose
The company intends to use the funds for the commercial launch of two medical foods designed for the dietary management of bone health and rheumatoid arthritis, respectively.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
100 Edwin H Land Blvd.
Cambridge, MA 02142
USA
Cambridge, MA 02142
USA
Phone
Undisclosed
Website
Email Address
Overview
The Solarea breakthrough came from the combined efforts of the company's co-founders who established a link between the discovery of an untapped source of microorganisms with probiotic potential in healthy foods, and their applications in inflammatory processes including the gut-musculoskeletal axis.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Gerardo Toledo
VP - General Counsel
Gregory Sieczkiewicz
VP - R & D
Eric Schott
Browse more venture capital transactions:
Prev: 5/9/2023: Artifact Labs venture capital transaction
Next: 5/10/2023: Previero venture capital transaction
Share this article
About Our VC Transactions Data
We do our best to record every notable VC transaction. VC investment data records on this site come from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs